上海证券报地方级
海翔药业盈利持续提升 基金二季度“结伙”入驻
吴正懿裘海亮
Snapshot of full-text:
海翔药业今日披露的半年报显示,报告期内,公司实现营业总收入5.16亿元,同比增长24.7%;归属于上市公司股东的净利润4676.7万元,同比增长236.85%;基本每股收益0.29元。 报告期内,海翔药业的产品综合毛利率较上年同期提高了8.1个百分点,原因是公司产品结构改善,附
Newspaper Date:
2010-08-27
Edition No:
公司
Edition Code:
F08
- Series:
(J) Economics & Management
- Subject:
Finance; Securities; Investment
- Classification Code:
F832.51
- Mobile Reading
Read on your phone instantly
Step 1
Scan QR Codes
"Mobile CNKI-CNKI Express" App
Step 2
Open“CNKI Express”
and click the scan icon in the upper left corner of the homepage.
Step 3
Scan QR Codes
Read this article on your phone.
- Download
- Online Reading
- AI Summary

Download the mobile appuse the app to scan this coderead the article.
Tips: Please download CAJViewer to view CAJ format full text.
Download: 20 Pagecount: -1 Size: -1k
Related Literature
- Similar Article
- Readers' Recommendations
- [1]海翔药业修改激励方案 董事长无缘股份成“看客”[N]. 吴正懿,李小兵. 上海证券报. 2010-06-29 (F08)
- [2]海翔药业拟募资5亿布局下游 华夏与嘉实四季度加仓被套[N]. 徐锐. 上海证券报. 2011-02-25 (F07)
- [3]净利润猛增182.59% 海翔药业拟募资5.2亿元扩产能[N]. 陈雅琼. 证券日报. 2011-02-25 (A03)
- [4]海翔药业 一季度业绩预增四到七成[N]. 郭成林. 上海证券报. 2011-03-16 (F10)
- [5]海翔药业大股东减持[N]. 龙昊. 中国经济时报. 2010-02-02 (008)
- [6]海翔药业控股股东7次减持套现1.8亿元[N]. 夏芳. 证券日报. 2010-09-10 (C03)
- [7]五折转让股权 海翔药业大股东“父传子”[N]. 吴正懿,祝建华. 上海证券报. 2010-09-21 (F09)
- [8]白云山A、海翔药业分别遭股东减持[N]. 华锋. 中国医药报. 2009-01-22 (B03)
- [9]海翔药业[N]. 中国证券报. 2006-12-26 (B02)
- [10]复星医药投资海翔药业三年增值10倍[N]. 蒋晔. 证券时报. 2006-12-27 (C02)